Navigation Links
Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management
Date:8/30/2007

Findings Validate Importance of Allergy Testing in Managing Chronic

Condition

PORTAGE, Mich., Aug. 30 /PRNewswire/ -- Phadia US Inc. announced today that The National Asthma Education and Prevention Program (NAEPP) has issued an update on selected topics in the Guidelines for the Diagnosis and Management of Asthma. Information in the guidelines reported that allergies have emerged as one of the most important factors in the development, persistence and potential severity of asthma and that allergy testing is necessary to educate patients about allergen avoidance and symptom control.

"The role of allergy testing in asthma management is important information for patients, particularly because many asthmatics are not aware that a simple blood test can be conducted to identify what is triggering an asthma attack," said Dean Mitchell, MD, leading allergist and author of Dr. Dean Mitchell's Allergy and Asthma Solution. "Allergy diagnostic testing using a specific IgE blood test is a safe and accurate method to identify triggers early on and effectively manage patients."

The Guidelines were developed by an expert panel commissioned by the National Asthma Education and Prevention Program and coordinated by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health to ensure that the asthma guidelines reflect the latest scientific advances in this area. The guidelines were first published in 1991 and revised in 1997 and 2002. These latest parameters highlight the importance of keeping asthma under control through four critical components of asthma care, including: assessment and monitoring, patient education, control of environmental factors contributing to asthma severity, and pharmacologic therapy.

"As the presence of allergens increases this fall allergy season, it will be critical for patients to understand what their allergic triggers are and how to avoid those allergens," said Dr. Mitchell. "By accurately diagnosing allergies, healthcare providers can recommend avoidance strategies, so that patients can minimize their exposure to triggers, which collectively are responsible for pushing them over their allergic threshold and intensifying asthma symptoms."

According to the guidelines, approximately 22 million Americans have asthma and more than six million of these are children, making it one of the most common chronic diseases of childhood. While the number of asthma-related deaths has declined in recent years, nearly 500,000 asthma-related hospitalizations occur annually resulting in a significant economic burden on our healthcare system.

"Knowledge gained from allergy testing allows asthma patients to make necessary adjustments to their environment to decrease their risk for asthma attacks and subsequent hospitalizations," said Dr. Mitchell.

ImmunoCAP was the first allergy test to be cleared by the FDA as a truly quantitative test for pinpointing allergens and allergy blood testing is recognized by the National Institutes of Health for the management of patients with asthma. The ImmunoCAP technology works by measuring IgE antibodies to specific allergens in a small sample of blood. Specific IgE is produced as a result of sensitization to an allergen and increases with exposure to that substance.

Phadia AB, headquartered in Uppsala, Sweden, is the world leader in in vitro IgE diagnostic research and product development. Its U.S. affiliate is in Portage, Michigan.


'/>"/>
SOURCE Phadia US Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Merge unveils updated medical imaging software
2. Dane County mapping software updated, available to public
3. Lands End Debuts Updated Virtual Model
4. siRNA Design Guidelines
5. Federal and global guidelines on stem cell research offer a level playing field
6. With ethics guidelines, political consensus emerging on stem-cell research
7. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
8. Ambion Offers Gene Expression Profiling Service
9. CIO Leadership Series: Snap-Ons Moreno offers lessons in IT transformation
10. In pursuit of capital, be sure to track your private offering
11. Ethics Board site offers welcome contrast to state IT mistakes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:6/14/2017)... (NYSE: IBM ) is introducing several innovative partner startups ... collaboration between startups and global businesses, taking place in ... nine startups will showcase the solutions they have built with ... France is one of the ... percent increase in the number of startups created between 2012 ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):